Table of Content

Chapter 1 Introduction
Overview
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Geographic Breakdown

Chapter 2 Summary and Highlights

Chapter 3 Market Overview
History
Distribution Trends
HAT Causing Parasites
Clinical Features of HAT
Diagnosis of HAT
Antibody Detection
Parasite Detection
Future Perspectives
Population Screening

Chapter 4 Sleeping Sickness by Disease Types
Overview
Trypanosoma Brucei Gambiense
Diagnosis of T. b. Gambiense
Trypanosoma Brucei Rhodesiense
Diagnosis of T. b. Rhodesiense

Chapter 5 Sleeping Sickness by Treatments
Overview
Drugs for HAT Treatment
Product Pipeline

Chapter 6 Competitive Landscape
Competitive Analysis

Chapter 7 Company Profiles
BAYER AG
SANOFI

Chapter 8 Appendix: Acronyms



List of Figures


Figure 1 : Life Cycle of Human African Trypanosomiasis (HAT)
Figure 2 : Life Cycle of the Trypanosome Parasite
Figure 3 : Bayer AG: Annual Revenue, 2021 and 2022
Figure 4 : Bayer AG: Revenue Shares, by Business Unit, 2022
Figure 5 : Bayer AG: Revenue Shares, by Region, 2022
Figure 6 : Sanofi: Annual Revenue, 2021 and 2022
Figure 7 : Sanofi: Revenue Shares, by Business Unit, 2022
Figure 8 : Sanofi: Revenue Shares, by Region, 2022

List of Tables


Table 1 : HAT Types and Their Differences
Table 2 : Anti-Trypanosomal Treatment for HAT
Table 3 : Bayer AG: Product Portfolio
Table 4 : Bayer AG: Annual Revenue, 2021 and 2022
Table 5 : Bayer AG: News
Table 6 : Sanofi: Product Portfolio
Table 7 : Sanofi: Annual Revenue, 2021 and 2022
Table 8 : Sanofi: News
Table 9 : Acronyms Used in This Report